Sort
172,184 grants matching “inflammation”
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
$828,290Takashi Tsukamoto · Johns Hopkins University · R01 · FY2022 · AG
Defining neutrophil pathobiology in pediatric Long COVID
$828,233Lael Yonker · Massachusetts General Hospital · R01 · FY2024 · HL
Innovative Investigations and Therapies for Asthma
$828,212National Jewish Health · U10 · FY2004 · HL
An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease
$828,195Marina Sirota · University Of California, San Francisco · R01 · FY2019 · AG
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
$828,127John Koethe · Vanderbilt University Medical Center · R01 · FY2019 · DK
Oxidation Resistant ApoA1 Gene Delivery Stents
$828,102Robert J Levy · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Pathophysiology of Renal Allograft Dysfunction
$828,097Duke University · P01 · FY2005 · DK
The Risk of Myocardial Infarction in Patients with Psoriasis
$828,093Joel M Gelfand · University Of Pennsylvania · R01 · FY2010 · HL
Immune based interventions for HIV eradication
$828,064Mirko Paiardini · Emory University · R01 · FY2018 · AI
Research training in respiratory biology
$828,000Gokhan M. Mutlu · University Of Chicago · T32 · FY2021 · HL
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
$827,951Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$827,944Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
$827,942Luis J. Montaner · Wistar Institute · R01 · FY2019 · DA
Impact of Prolonged Sedentary Behavior on Cardiac Outcomes and Mortality in Acute Coronary Syndrome Patients
$827,914Keith M Diaz · Columbia University Health Sciences · R01 · FY2018 · HL
Targeting Angiopoietin-like 4 (ANGPTL4) in Severe Community Acquired Pneumonia
$827,909Pavan Kumar Bhatraju · University Of Washington · R01 · FY2025 · HL
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$827,898Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease
$827,892Stephen Dean Turley · Ut Southwestern Medical Center · R01 · FY2013 · HL
Antibody Responses in Aging SIV Infected Monkeys
$827,888Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
Chylomicrons and endothelial biology
$827,884Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2025 · HL
Chylomicrons and endothelial biology
$827,884Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2023 · HL
PET/CT-Guided Personalized Mechanical Ventilation to Minimize Ventilator-Induced Lung Injury
$827,878Marcos F Vidal Melo · Massachusetts General Hospital · R01 · FY2021 · HL
Neurodifferentiation/Stem Cell Unit
$827,865David Wang · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$827,788Charles T Roberts · Oregon Health & Science University · R01 · FY2020 · DK
Endothelial-to-mesenchyma transition and atherosclerosis
$827,743Martin A. Schwartz · Yale University · R01 · FY2017 · HL
Imaging the Pulmonary Circulation to Aid Personalized Management of Acute Respiratory Distress Syndrome
$827,682Maurizio Franco Cereda · Massachusetts General Hospital · R01 · FY2024 · HL